echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Peking University People's Hospital Shen Zhanlong's research group and collaborators published research results in authoritative academic journals, revealing that Asian-specific IgG1 memory B cell antigen receptor changes...

    Peking University People's Hospital Shen Zhanlong's research group and collaborators published research results in authoritative academic journals, revealing that Asian-specific IgG1 memory B cell antigen receptor changes...

    • Last Update: 2022-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On March 15, 2022, Shen Zhanlong's research group from the Department of Gastrointestinal Surgery of Peking University People's Hospital and Liu Wanli's research group from the Institute of Immunology, School of Life Sciences, Tsinghua University cooperated to tackle key problems in the field of IgG1 memory B lymphocytes regulating the immune microenvironment of colorectal tumors.


    The importance of T cells in tumor immune evasion and as a target for drug therapy has been recognized, but relatively little research has been done on B cells


    The researchers conducted epidemiological analysis on a cohort of more than 1,000 colorectal cancer patients and found that tumor patients with the hIgG1-G396R homozygous genotype can significantly improve overall prognosis and survival and progression-free survival.


    The above studies indicate that the hIgG1-G396R variant may be an important protective prognostic factor for patients with colorectal cancer, revealing that hIgG1-G396R has the potential to be used as a prognostic indicator in the field of colorectal cancer, and provide a reference for patients' survival prediction, medication guidance, etc.


    Dr.


     Schematic illustration of the IgG1 memory B-cell antigen receptor membrane-linked heavy chain hIgG1-G396R variant remodeling the colorectal cancer tumor microenvironment and enhancing antitumor immunity


    Expert introduction


    Shen Zhanlong, Chief Physician, Professor, Doctoral Supervisor of Gastrointestinal Surgery, Peking University People's Hospital, Deputy Director of the Surgical Oncology Laboratory


    Introduction of cooperation experts

    Liu Wanli is a tenured professor and doctoral supervisor of the School of Life Sciences of Tsinghua University, a researcher of the Institute of Immunology of Tsinghua University and the Joint Center for Life Sciences of Tsinghua University and Peking University


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.